CTA/CDX development From Concept to Market

HalioDx provides professional framework for Clinical Trial Assay (CTA) and Companion Diagnostics (CDx) development.

It covers development, manufacturing, life cycle management, regulatory and marketing support and commercialization.

Thanks to its strong expertise and its compliant capabilities and processes, HalioDx successfully develops CDx tests eligible for a co-registration with the FDA and cover the whole drug development process with strong responsibilities :

  • Biomarker discovery & Design Concept
  • Assay Development (CTA)
  • Proof of Concept
  • Assay Validation
  • Clinical trial
  • PMA submission
  • Post Launch

HalioDx all along the drug development process

A proven expertise to assist biopharma with innovative technologies and workflows

More on our Assay Development capabilities Discover
Contact our team today, and let's talk about your project
Contact us

HalioDx newsletter subscription


Join our newsletter and be the first to get notified on new updates.


× Hide this popup.